We take a deep dive into what we currently understand about right ventricular failure that occurs with pulmonary arterial hypertension.
French researchers have proposed that an overlooked aspect of PAH is the phenotypic diversity of vascular smooth muscle cells (SMCs).
New experimental therapies for pulmonary arterial hypertension promise to target specific molecular pathways associated with the pathophysiology of the disease.
Beyond the headlines and in the cold realities of hospital wards, the COVID-19 pandemic has wreaked havoc as physicians scramble to come up with a list of new protocols to manage the influx of highly contagious patients. The COVID-19 pandemic has already upended the neatly divided lines in the hospital wards. In the past, separate…